Literature DB >> 26895836

Vitamin D [1,25(OH)2D3] Differentially Regulates Human Innate Cytokine Responses to Bacterial versus Viral Pattern Recognition Receptor Stimuli.

Natascha Fitch1, Allan B Becker2, Kent T HayGlass3.   

Abstract

Vitamin D plays multiple roles in regulation of protective and maladaptive immunity. Although epidemiologic studies link poor in vivo 25(OH)D status to increased viral respiratory infections, we poorly understand how vitamin D affects viral pattern recognition receptor (PRR)-driven cytokine production. In this study, we hypothesized that the biologically active metabolite of vitamin D, 1,25(OH)2D3, inhibits human proinflammatory and anti-inflammatory innate cytokine responses stimulated by representative bacterial or viral PRR ligands. Fresh PBMCs or CD14(+) monocytes were stimulated with TLR4, TLR7/8-selective ligands, or respiratory syncytial virus (RSV) ± 1,25(OH)2D3. Proinflammatory and anti-inflammatory responses resulting from TLR4 stimulation were inhibited ∼50% in the presence of 1,25(OH)2D3. Conversely, its usage at physiologic through pharmacologic concentrations inhibited neither proinflammatory nor anti-inflammatory responses evoked by viral PRR ligands or infectious RSV. This differential responsiveness was attributed to the finding that TLR7/8, but not TLR4, stimulation markedly inhibited vitamin D receptor mRNA and protein expression, selectively reducing the sensitivity of viral PRR responses to modulation. 1,25(OH)2D3 also enhanced expression of IkBa, a potent negative regulator of NF-κB and cytokine production, in TLR4-stimulated monocytes while not doing so upon TLR7/8 stimulation. Thus, 1,25(OH)2D3 inhibits both proinflammatory and a broad panel of anti-inflammatory responses elicited by TLR4 stimulation, arguing that the common view of it as an anti-inflammatory immune response modifier is an oversimplification. In viral responses, it consistently fails to modify TLR7/8- or RSV-stimulated innate cytokine production, even at supraphysiologic concentrations. Collectively, the data call into question the rationale for increasingly widespread self-medication with vitamin D supplements.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26895836     DOI: 10.4049/jimmunol.1500460

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Vitamin D signaling maintains intestinal innate immunity and gut microbiota: potential intervention for metabolic syndrome and NAFLD.

Authors:  Yilan Zeng; Mei Luo; Liwei Pan; Yuan Chen; Siqi Guo; Dongxia Luo; Li Zhu; Yong Liu; Lisha Pan; Siya Xu; Ruofei Zhang; Chunyan Zhang; Pengfei Wu; Liangpeng Ge; Mazen Noureddin; Stephen J Pandol; Yuan-Ping Han
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-27       Impact factor: 4.052

2.  Vitamin D deficiency in critically ill COVID-19 ARDS patients.

Authors:  Quirin Notz; Johannes Herrmann; Tobias Schlesinger; Peter Kranke; Magdalena Sitter; Philipp Helmer; Jan Stumpner; Daniel Roeder; Karin Amrein; Christian Stoppe; Christopher Lotz; Patrick Meybohm
Journal:  Clin Nutr       Date:  2021-03-07       Impact factor: 7.643

3.  Low vitamin D status is associated with inflammation in patients with prostate cancer.

Authors:  Dong-Dong Xie; Yuan-Hua Chen; Shen Xu; Cheng Zhang; Da-Ming Wang; Hua Wang; Lei Chen; Zhi-Hui Zhang; Mi-Zhen Xia; De-Xiang Xu; De-Xin Yu
Journal:  Oncotarget       Date:  2017-03-28

4.  Effects of calcitriol (1, 25-dihydroxy-vitamin D3) on the inflammatory response induced by H9N2 influenza virus infection in human lung A549 epithelial cells and in mice.

Authors:  Boxiang Gui; Qin Chen; Chuanxia Hu; Caihui Zhu; Guimei He
Journal:  Virol J       Date:  2017-01-23       Impact factor: 4.099

5.  Dietary vitamin D3 supplementation protects laying hens against lipopolysaccharide-induced immunological stress.

Authors:  Yanqiang Geng; Qiugang Ma; Zhong Wang; Yuming Guo
Journal:  Nutr Metab (Lond)       Date:  2018-08-10       Impact factor: 4.169

Review 6.  Vitamin D and Influenza-Prevention or Therapy?

Authors:  Beata M Gruber-Bzura
Journal:  Int J Mol Sci       Date:  2018-08-16       Impact factor: 5.923

Review 7.  Vitamin D-Regulated MicroRNAs: Are They Protective Factors against Dengue Virus Infection?

Authors:  John F Arboleda; Silvio Urcuqui-Inchima
Journal:  Adv Virol       Date:  2016-05-11

8.  Low serum vitamin D levels in type 2 diabetes patients are associated with decreased mycobacterial activity.

Authors:  María Teresa Herrera; Yolanda Gonzalez; Fernando Hernández-Sánchez; Guadalupe Fabián-San Miguel; Martha Torres
Journal:  BMC Infect Dis       Date:  2017-09-07       Impact factor: 3.090

9.  Human macrophages differentiated in the presence of vitamin D3 restrict dengue virus infection and innate responses by downregulating mannose receptor expression.

Authors:  John F Arboleda Alzate; Izabela A Rodenhuis-Zybert; Juan C Hernández; Jolanda M Smit; Silvio Urcuqui-Inchima
Journal:  PLoS Negl Trop Dis       Date:  2017-10-11

Review 10.  Controversial Effects of Vitamin D and Related Genes on Viral Infections, Pathogenesis, and Treatment Outcomes.

Authors:  Choongho Lee
Journal:  Nutrients       Date:  2020-03-30       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.